Search
Intellia Therapeutics Inc
NTLAAdd to Watchlist
15.670USD
+0.470+3.09%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.89BMarket Cap
LossP/E TTM
Intellia Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Intellia Therapeutics Inc is 6.45, ranking 334 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.46, which is -73.06% below the recent high of -1.20 and -92.28% above the recent low of -8.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
